Alps Advisors Inc Vanda Pharmaceuticals Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 44,036 shares of VNDA stock, worth $212,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,036
Previous 45,396 3.0%
Holding current value
$212,693
Previous $256,000 19.53%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$4.61 - $6.34 $6,269 - $8,622
-1,360 Reduced 3.0%
44,036 $206,000
Q2 2024

Aug 13, 2024
BUY
$3.91 - $6.5 $18,814 - $31,278
4,812 Added 11.86%
45,396 $256,000
Q1 2024

May 14, 2024
BUY
$3.47 - $4.61 $527 - $700
152 Added 0.38%
40,584 $166,000
Q4 2023

Feb 14, 2024
SELL
$3.38 - $4.58 $6,641 - $8,999
-1,965 Reduced 4.63%
40,432 $170,000
Q3 2023

Nov 14, 2023
BUY
$4.28 - $6.57 $740 - $1,136
173 Added 0.41%
42,397 $183,000
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $28,402 - $33,457
4,814 Added 12.87%
42,224 $278,000
Q1 2023

May 10, 2023
SELL
$6.18 - $7.99 $6,631 - $8,573
-1,073 Reduced 2.79%
37,410 $254,000
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $52,727 - $84,118
7,675 Added 24.91%
38,483 $284,000
Q3 2022

Nov 14, 2022
SELL
$9.44 - $11.76 $25,525 - $31,799
-2,704 Reduced 8.07%
30,808 $304,000
Q2 2022

Aug 11, 2022
SELL
$9.31 - $11.84 $222,909 - $283,485
-23,943 Reduced 41.67%
33,512 $365,000
Q1 2022

May 16, 2022
SELL
$10.84 - $16.55 $76,031 - $116,081
-7,014 Reduced 10.88%
57,455 $650,000
Q4 2021

Feb 09, 2022
SELL
$15.69 - $21.14 $58,429 - $78,725
-3,724 Reduced 5.46%
64,469 $1.01 Million
Q3 2021

Nov 15, 2021
SELL
$15.35 - $21.27 $76,627 - $106,179
-4,992 Reduced 6.82%
68,193 $1.17 Million
Q2 2021

Aug 11, 2021
SELL
$15.71 - $21.51 $410,109 - $561,518
-26,105 Reduced 26.29%
73,185 $1.57 Million
Q1 2021

May 07, 2021
SELL
$13.42 - $20.28 $358,367 - $541,557
-26,704 Reduced 21.19%
99,290 $1.49 Million
Q4 2020

Feb 03, 2021
BUY
$9.77 - $13.81 $957,010 - $1.35 Million
97,954 Added 349.34%
125,994 $1.66 Million
Q3 2020

Nov 04, 2020
BUY
$9.32 - $12.02 $261,332 - $337,040
28,040 New
28,040 $271,000
Q1 2020

May 06, 2020
SELL
$7.5 - $16.8 $192,495 - $431,188
-25,666 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$12.38 - $17.47 $13,816 - $19,496
-1,116 Reduced 4.17%
25,666 $421,000
Q3 2019

Nov 04, 2019
BUY
$12.27 - $15.79 $79,730 - $102,603
6,498 Added 32.04%
26,782 $356,000
Q2 2019

Aug 07, 2019
SELL
$13.37 - $18.85 $14,305 - $20,169
-1,070 Reduced 5.01%
20,284 $286,000
Q1 2019

May 01, 2019
BUY
$17.59 - $31.05 $375,616 - $663,041
21,354 New
21,354 $393,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $273M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email